Richard von Culin

Richard Von Culin has extensive work experience in the pharmaceutical industry. Richard currently holds the position of Executive Director Regulatory, Quality, Pharmacovigilance at Kowa Pharmaceuticals America, Inc., where they oversee various aspects including quality, sales and marketing compliance, regulatory affairs, and post-marketing surveillance. Prior to this role, they served as the Director of Quality Assurance at the same company, responsible for ensuring compliance with quality management systems and maintaining product quality.

Before joining Kowa Pharmaceuticals, Richard worked at Sanofi as a Quality System Management professional from 2019 to 2021. Richard also had a long tenure at Boehringer Ingelheim, where they held several positions including Associate Director in Clinical Operations and Process Improvement Trial Oversight, Associate Director in Regulatory Affairs Submission Systems and Process Improvement, Manager in Promotional Materials, and Manager in Clinical Quality Assurance/Regulatory Compliance. In these roles, they successfully completed various global projects and initiatives to improve processes and systems within the company.

Earlier in their career, Richard worked at CuraGen as a Senior Software Developer and at Bristol-Myers Squibb as a Research Associate. Overall, Richard Von Culin has a strong background in quality assurance, regulatory affairs, process improvement, and project management within the pharmaceutical industry.

Richard Von Culin obtained a Bachelor of Arts (BA) degree in Biology from Lycoming College in 1989. Richard later completed a Master of Business Administration (MBA) degree with a focus on the Pharmaceutical Industry at Fairleigh Dickinson University from 1995 to 2000. Currently, Richard is pursuing a PhD in Applied Management and Decision Sciences from Walden University.